LCM
ATRC icon

Laurion Capital Management’s AtriCure ATRC Stock Holding History

Laurion Capital Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-51,831
Closed -$945K – 1316
2017
Q4 		$945K Sell
51,831
-255,378
-83% -$5.06M ﹤0.01% 982
2017
Q3 		$6.87M Buy
+307,209
New +$6.95M 0.03% 416

Other funds holding ATRC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Laurion Capital Management's ATRC Position: Q1 2018 in Review

Laurion Capital Management sold out of AtriCure (ATRC) in Q1 2018, closing a stake of 51,831 shares — an estimated $945K sold.

Laurion Capital Management first reported a position in ATRC in Q3 2017 and held it in 2 quarters. The position peaked at $6.87M in Q3 2017. 108 funds tracked by Wall St. Rank hold ATRC as of Q1 2018.

  • Laurion Capital Management reported no remaining AtriCure position as of Q1 2018 after selling out during the quarter.
  • Laurion Capital Management sold 51,831 AtriCure shares in Q1 2018, an estimated $945K.
  • Laurion Capital Management first reported a position in AtriCure in Q3 2017 and held it in 2 quarters.
  • Laurion Capital Management's AtriCure position peaked at $6.87M in Q3 2017.
  • 108 funds tracked by Wall St. Rank held AtriCure as of Q1 2018.

Based on Laurion Capital Management's 13F filing for Q1 2018, filed 14 May 2018.